The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

Experts say growing awareness about the difference between screening and diagnostic tests can help families make informed ...

Pregnancy care is now being transformed from its traditional, observational monitoring approach into a proactive, precision-led process, thanks to antenatal genomics.

For decades, the accepted explanation for the origins of the Japanese people was relatively straightforward. Modern Japanese ...

International momentum is evidenced by the 2026 symposium attracting participants from 73 countries, and highlighting OGM ...

There was a time when pregnancy tests did not merely announce impending parenthood. They opened the door to nine months of ...

Looking back on life sciences tools & services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

Genomic assays have become indispensable tools in the management of early-stage invasive breast cancer, helping oncologists move beyond traditional pathologic staging to make more ...

Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2026. "The Bionano business is healthy, with first ...

Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation with TipRanks’ trus ...

The Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific is designed for fast, scalable sample analysis. Paired with the Applied Biosystems Axiom™ PharmacoPro™ Array ...